or Try an Advanced Search...

    Technical Analysis for TYP - Tryptamine Therapeutics Limited

    Grade Last Price % Change Price Change
    B 0.044 10.00% 0.004
    TYP closed down 16.67 percent on Tuesday, December 3, 2024, on 1.28 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A Up Down
    Historical TYP trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 10.00%
    Wide Range Bar Range Expansion 10.00%
    Stochastic Reached Oversold Weakness 10.00%
    Wide Bands Range Expansion 10.00%
    Gapped Up Strength 10.00%
    Oversold Stochastic Weakness 10.00%
    Crossed Above 20 DMA Bullish -8.33%
    Wide Bands Range Expansion -8.33%
    Gapped Up Strength -8.33%
    Shooting Star Candlestick Bearish 0.00%
    Older End-of-Day Signals for TYP ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Partially Closed about 1 hour ago
    Gapped Up (Partial) about 2 hours ago
    10 DMA Resistance about 2 hours ago
    Up 5% about 2 hours ago
    Up 2% about 2 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TYP Chart by TradingView
    Basic chart:

    Profile

    Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Development

    Is TYP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.057
    52 Week Low 0.017
    Average Volume 4,229,211
    200-Day Moving Average 0.000
    50-Day Moving Average 0.031
    20-Day Moving Average 0.045
    10-Day Moving Average 0.045
    Average True Range 0.004
    RSI (14) 49.75
    ADX 50.08
    +DI 28.152
    -DI 16.235
    Chandelier Exit (Long, 3 ATRs) 0.045
    Chandelier Exit (Short, 3 ATRs) 0.042
    Upper Bollinger Bands 0.053
    Lower Bollinger Band 0.038
    Percent B (%b) 0.15
    BandWidth 32.743
    MACD Line 0.004
    MACD Signal Line 0.005
    MACD Histogram -0.0013
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.055
    Resistance 3 (R3) 0.057 0.053 0.053
    Resistance 2 (R2) 0.053 0.050 0.053 0.052
    Resistance 1 (R1) 0.047 0.047 0.045 0.045 0.051
    Pivot Point 0.043 0.043 0.043 0.043 0.043
    Support 1 (S1) 0.037 0.040 0.035 0.035 0.029
    Support 2 (S2) 0.033 0.037 0.033 0.028
    Support 3 (S3) 0.027 0.033 0.028
    Support 4 (S4) 0.025